收藏切换
Advances in the effects and mechanisms of drugs and xenobiotics on bone development
收藏切换
PDF
Li-ming CHONG1, 2, Si-yu LIU1, Yang YANG1, Chi-yang ZHENG1, Ting ZHANG1
Chinese Journal of Clinical Pharmacology | 2026, 42(3) : 427 - 433
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2026, 42(3): 427-433
Review
Advances in the effects and mechanisms of drugs and xenobiotics on bone development
Full
Li-ming CHONG1, 2, Si-yu LIU1, Yang YANG1, Chi-yang ZHENG1, Ting ZHANG1
Affiliations
  • 1.NHC Key Lab of Reproduction Regulation, Shanghai Engineering Research Center of Reproductive Health Drug and Devices, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai 200237, China
  • 2.School of Life Sciences, Xiamen University, Xiamen 361000, Fujian Province, China
Published: 2026-02-17 doi: 10.13699/j.cnki.1001-6821.2026.03.020
Outline
收藏切换

Bone is not a static scaffold but a highly dynamic organ, whose development and homeostasis are significantly influenced by various drugs and xenobiotics. While traditional research has primarily focused on nutritional, hormonal, and genetic factors affecting bone, growing evidence highlights drugs and xenobiotics exposure as critical, non-negligible risk factors for bone health. This review systematically summarizes and analyzes the pharmacological impact of drugs (such as aromatase inhibitors, tyrosine kinase inhibitors, insulin sensitizers and antibiotics) and xenobiotics (such as heavy metals, environmental pollutants and endocrine disruptors) on bone development and metabolism. It emphasizes their roles in disrupting bone metabolic balance—through mechanisms including interference with signaling pathways, induction of oxidative stress, mimicry or antagonism of endocrine hormones, triggering of chronic inflammation, and induction of epigenetic alterations—leading to impaired bone microstructure, reduced bone strength, and increased fracture risk. Additionally, this review compiles potential bone-protective drugs and exogenous nutrients, evaluating their pharmacological actions in promoting bone health via supplemental osteogenic substrates, modulation of osteoblast/osteoclast activity, and repair of bone metabolic damage. The aim of this synthesis is to provide a pharmacological foundation for assessing risks posed by drugs and related xenobiotics to bone development and to offer new perspectives for preventing and treating bone-related disorders.

drugs  /  xenobiotics  /  bone development  /  toxicity  /  protective effects  /  mechanism
Li-ming CHONG, Si-yu LIU, Yang YANG, Chi-yang ZHENG, Ting ZHANG. Advances in the effects and mechanisms of drugs and xenobiotics on bone development[J]. Chinese Journal of Clinical Pharmacology, 2026 , 42 (3) : 427 -433 . DOI: 10.13699/j.cnki.1001-6821.2026.03.020
Year 2026 volume 42 Issue 3
PDF
368
247
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2026.03.020
  • Receive Date:2025-11-18
  • Online Date:2026-08-06
  • Published:2026-02-17
Article Data
Affiliations
History
  • Received:2025-11-18
Affiliations
    1.NHC Key Lab of Reproduction Regulation, Shanghai Engineering Research Center of Reproductive Health Drug and Devices, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai 200237, China
    2.School of Life Sciences, Xiamen University, Xiamen 361000, Fujian Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2026.03.020
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT